Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07076368 · ClinicalTrials.gov registry record · Phase 3
Ropivacaine and Fentanyl for Labor Epidural Initiation
A Phase 3 study of Pregnancy and Labor Analgesia, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07076368 is a Phase 3 study of Pregnancy and Labor Analgesia that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 50 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07076368, a Phase 3 study of Pregnancy and Labor Analgesia, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to determine the most effective dose of medicine to use to initially provide effective pain relief within the first 30 minutes of receiving an epidural for pain labor during labor. The study team will also study any side effects related to the epidural medication and patients' satisfaction with the quality of pain relief after receiving the epidural.
Conditions Studied
Interventions
- DRUG Ropivacaine + Fentanyl
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-10-24 |
| Est. Completion | 2026-07-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07076368
The ClinicalTrials.gov registry entry for NCT07076368 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (94% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Ropivacaine + Fentanyl is the first listed.
NCT07076368 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07076368 about?
NCT07076368 is a clinical study titled "Ropivacaine and Fentanyl for Labor Epidural Initiation". This study is being done to determine the most effective dose of medicine to use to initially provide effective pain relief within the first 30 minutes of receiving an epidural for pain labor during labor. The study team will also study any side effects related to the epidural medication and patient...
What is the current status of trial NCT07076368?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 50 participants. The study started on 2025-10-24. Estimated completion is 2026-07-31.
What conditions does trial NCT07076368 study?
This clinical trial studies the following conditions: Pregnancy, Labor Analgesia, Labor and Delivery.
What interventions are being tested in trial NCT07076368?
The interventions under investigation include: Ropivacaine + Fentanyl (DRUG).
Who is sponsoring clinical trial NCT07076368?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07076368 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Different Medications to Induce Labor
RECRUITING · Phase 3
-
Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy
RECRUITING · Phase 3
-
A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
COMPLETED · Phase 3
-
The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants
COMPLETED · Phase 3
-
Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE)
COMPLETED · Phase 3
-
Comparison of Foley Balloon With or Without Traction for the Cervical Ripening
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.